英语释义

• a protein in blood plasma that is the inactive precursor of thrombin

片语

prothrombin assay凝血酶原测定

prothrombin time[病理] 前凝血酶时间

Prothrombin Ratio凝血酶原比率

prothrombin E凝血酶原

Prothrombin determination凝血酶原测定

prothrombin kit凝血酶原测定箱

prothrombin times[病理] 前凝血酶时间

prothrombin mRNA凝血酶原mRNA

Prothrombin Reagent凝血素试药

prothrombin precursor凝血酶前体

英汉例句

• however, there was no significant difference in the total bilirubin and prothrombin time in either group during the observation periods.

  然而，观察期间在总胆红素和凝血酶原时间方面两组之间没有显着差异。

• borosilicate glass vial, sealed with bromobutyl rubber stopper, packaging of 1 set per carton. 1 set contains a vial of human prothrombin complex, and solution.

  硼硅玻璃模制注射剂瓶、溴化丁基橡胶塞包装。1套/盒。1套包含人凝血酶原复合物1瓶，人凝血酶原复合物溶解液1瓶。

• objective to explore effects of blood platelets and prothrombin time on mifepristone.

  目的探讨米非司酮对血小板、血浆凝血酶原时间的影响。

• methed: 167 cases of valve replacement vere followed - up to research the prothrombin time for 1 - 8 years.

  方法：对167例心脏机械瓣替换术的病人进行1～8年的凝血酶原时间随访研究。

• technical conditions for adsorption and separation of prothrombin complex concentrates from human plasma with cg-6 macroporous anion-exchange resin were optimized.

  优化了cg-6型大孔阴离子交换树脂从人血浆中吸附和分离凝血酶原复合物的工艺条件。

• objective to explore the clinical significance of platelet, prothrombin time , activated partial thromboplastin time , thrombin time , plasma fibrinogen for parturient women.

  目的探讨临产孕妇血小板、凝血酶原时间、活化部分凝血活酶时间、凝血酶时间、纤维蛋白原检测的临床意义。

• in contrast, there wag no abnormal prothrombin in the rat plasma during its liver regeneration.

  诱癌早期的大鼠血浆即出现了高水平异常凝血酶原，它可用于肝癌的早期诊断。

• objective:to prepare a monoclonal antibody against prothrombin fragment 1+2(f1+2) and study its diagnostic effect in patients with thromboembolism.

  前言：目的：自制凝血酶原片段f1+2单克隆抗体，探讨其在血栓性疾病中的诊断作用。

• prothrombin time and international normalized ratio should be carefully monitored in patients concurrently administered istodax and coumadin derivatives.

  凝血酶原时间和国际标準化比值应仔细监测患者同时管理istodax和香豆衍生物。

• results no prothrombin gene g20210a mutation was found in both patients and controls.

  结果所有受检者均未发现凝血酶原g20210a基因突变。

• objective:to monitor the curative effect of oral warfarin for the patients after heart mechanical valve displacement by the prothrombin time(pt).

  目的评价采用凝血酶原时间（pt）监测心脏机械型瓣膜置换术后患者口服华法林治疗效果的意义。

• after hbo therapy the levels of prothrombin time activity and aptt did not change significantly at various time points ( p > 0. 05 ).

  hbo治疗结束，各个时间点的凝血酶原时间活动度和aptt两项指标与治疗前比较，差异无统计学意义（p>0．05）。

• in high-dose group, the prothrombin time of was prolonged and the fibrinogen level was decreased after the lmwh treatment(p0.05).

  大剂量组治疗后凝血酶原时间延长、纤维蛋白原降低（p0.05）。

• purposeto study on the quality of human prothrombin complex concentrate so as to establish the same quality standard as the international standard of pcc.

  目的通过对国产人凝血酶原复合物（pcc）质量的研究，建立与国际接规的质量标準。

• purpose to establish the preparation procedure of human prothrombin complex concentrate(pcc)by using two-step gel chromatography to obtain high purity and high security product.

  目的应用两步凝胶色谱法制备高纯度、高安全性的人凝血酶原复合物（pcc）制剂。

• observe two groups blood gas analysis, blood rheology, prothrombin tim, e blood platelet and fibrinogen「s change and curative effect.

  分别观察治疗前后两组血气分析、血流变学、凝血酶原时间、血小板及纤维蛋白原的改变及临床疗效。

• conclusion:yunnan paiyao can increase platelet activating, accelerate local hemostasis, but has no influence on prothrombin and d-dimer content, thus will not increase the dangerous of thrombosis.

  结论：云南白药能增加血小板活化，促进局部止血，但它不影响凝血物质和d-二聚体的含量，不增加血栓形成的危险。

• objectives: using normal plasmas and criterion plasmas to establish a kind of accurate and feasible method that could measure international normalized ratio (inr) of prothrombin time (pt).

  目的：利用正常血浆和定标血浆，建立一种準确可靠、易于实验室开展的凝血酶原时间国际标準化比值检测方法。

• objective to investigate a possible association between the mutation of human prothrombin gene g20210a and coronary heart disease (chd).

  目的探讨凝血酶原基因g20210a突变与中国汉族人群冠心病的相关性。

• objective:to explore clinical significance of detecting prothrombin time(pt), the activated partial thromboplastin time(aptt), thrombin time(tt), plasma fibrinogen(fib) for parturient women.

  目的：探讨检测临产孕妇凝血酶原时间（pt）、活化部分凝血活酶时间（aptt）、凝血酶时间（tt）、纤维蛋白原（fib）的临床意义。

• methods:to examine and compare the levels of prothrombin time, activated partial thromboplastin time, fibrinogen, thrombin time in 40 patients with primary hepatic carcinoma.

  对原发性肝癌6 0例进行凝血酶原时间、活化部分凝血酶原时间、纤维蛋白原、凝血酶时间4项凝血指标进行检测和对比分析。

• conclusion: combination of cryoprecipitate and prothrombin complex concentrate for traumatic hemorrhage has better effects than cryoprecipitate or prothrombin complex concentrate alone.

  结论：联合应用冷沉淀与凝血酶原复合物在创伤性失血患者治疗中，联合输注组比单独输注组疗效更显着。

• the platelet count」s down to a thousand. prothrombin time「s way up at thirty, and he」s got fibrin degradation products.

  血小板计数下降到1000，凝血原酶时间上升到30，而且血液中有纤维蛋白降解产物。

• conclusions:①among all the clinical parameters, the major risk factors affecting prognosis of severe hepatitis included age, serum bilirubin level, prothrombin time and simultaneous encephalopathy.

  结论：①重型肝炎患者入院时的临床参数中，年龄、血清胆红素、凝血酶原时间、肝性脑病为影响预后的主要危险因素。

• purpose: the purpose of this study is to prepare prothrombin complex concentrate(pcc) conjugated anionic lipid microbubbles and to assess the physiochemical properties of the microbubbles.

  目的：制备结合凝血酶原复合物（pcc）的阴离子脂膜微泡，评价微泡的理化性质。

• in large-dose group, the prothrombin time was prolonged and the fibrinogen level was decreased after the treatment(p0.05).

  大剂量组治疗后凝血酶原时间延长、纤维蛋白原降低（p0.05）。

• objective to investigate the relationship between serum cholinesterase(che), prothrombin activity (pta) and the clinical type, disease condition and prognosis in the viral hepatitis patients.

  目的研究血清胆堿酯酶（che）、凝血酶原活动度（pta）与病毒性肝炎临床分型、病情及预后之间的关系。

• methods prothrombin fragments 1 and 2 (f1+2), fibrinopeptide a (fpa), soluble fibrin monomer complex(sfmc) were examined by enzyme linked immunoassay(elisa);

  方法采用酶联免疫分析法测定凝血酶原片段1+2 （f1+2 ）、纤维蛋白肽a（fpa）、可溶性纤维蛋白单体复合物（sfmc） ；